Torbener 
Active ingredients :  
Cefdinir 
300 mg Hard Gelatin Capsule 
250 mg / 5 ml or 125 mg/ 5 ml –Powder for Oral Suspension 

INDICATIONS AND USAGE  
TORBENER (cefdinir) is indicated for the treatment of patients with mild to moderate infections 
caused by susceptible strains of the designated microorganisms in the conditions listed below.  
Adults and Adolescents  
Community-Acquired Pneumonia: caused by Haemophilus influenzae (including β-lactamase 
producing strains), Haemophilus parainfluenzae (including β-lactamase producing strains), 
Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis 

(including βlactamase producing strains)  
Acute Exacerbations of Chronic Bronchitis: caused by Haemophilus influenzae (including β-lactamase 
producing strains), Haemophilus parainfluenzae (including β-lactamase producing strains), 
Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis 

(including β lactamase producing strains).  
Acute Maxillary Sinusitis: caused by Haemophilus influenzae (including β-lactamase producing 
strains), Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis 
(including βlactamase producing strains).  
Pharyngitis/Tonsillitis : caused by Streptococcus pyogenes   
Uncomplicated Skin and Skin Structure Infections : caused by Staphylococcus aureus (including β
lactamase producing strains) and Streptococcus pyogenes.  
Pediatric Patients  
Acute Bacterial Otitis Media caused by Haemophilus influenzae (including β-lactamase producing 
strains), Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis 
(including β-lactamase producing strains).  
Pharyngitis/Tonsillitis : caused by Streptococcus pyogenes. 
Uncomplicated Skin and Skin Structure Infections :caused by Staphylococcus aureus (including β
lactamase producing strains) and Streptococcus pyogenes.  
Cefdinir is effective in the eradication of S. pyogenes from the oropharynx.